Enzo Biochem (ENZ) Competitors $0.76 +0.05 (+7.05%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ENZ vs. BDSX, EUDA, QIPT, XGN, BNR, PIII, CCM, TOI, PMD, and MRAIShould you be buying Enzo Biochem stock or one of its competitors? The main competitors of Enzo Biochem include Biodesix (BDSX), EUDA Health (EUDA), Quipt Home Medical (QIPT), Exagen (XGN), Burning Rock Biotech (BNR), P3 Health Partners (PIII), Concord Medical Services (CCM), Oncology Institute (TOI), Psychemedics (PMD), and Marpai (MRAI). These companies are all part of the "healthcare" industry. Enzo Biochem vs. Biodesix EUDA Health Quipt Home Medical Exagen Burning Rock Biotech P3 Health Partners Concord Medical Services Oncology Institute Psychemedics Marpai Biodesix (NASDAQ:BDSX) and Enzo Biochem (NYSE:ENZ) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, media sentiment, community ranking, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk. Does the media favor BDSX or ENZ? In the previous week, Enzo Biochem had 6 more articles in the media than Biodesix. MarketBeat recorded 6 mentions for Enzo Biochem and 0 mentions for Biodesix. Biodesix's average media sentiment score of 0.00 beat Enzo Biochem's score of -0.35 indicating that Biodesix is being referred to more favorably in the media. Company Overall Sentiment Biodesix Neutral Enzo Biochem Neutral Do analysts prefer BDSX or ENZ? Biodesix presently has a consensus target price of $3.06, indicating a potential upside of 94.90%. Given Biodesix's stronger consensus rating and higher probable upside, equities analysts clearly believe Biodesix is more favorable than Enzo Biochem.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biodesix 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Enzo Biochem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is BDSX or ENZ more profitable? Biodesix has a net margin of -66.84% compared to Enzo Biochem's net margin of -81.73%. Enzo Biochem's return on equity of -11.84% beat Biodesix's return on equity.Company Net Margins Return on Equity Return on Assets Biodesix-66.84% -275.79% -43.05% Enzo Biochem -81.73%-11.84%-8.31% Which has more risk & volatility, BDSX or ENZ? Biodesix has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500. Comparatively, Enzo Biochem has a beta of 0.75, indicating that its stock price is 25% less volatile than the S&P 500. Do insiders & institutionals believe in BDSX or ENZ? 21.0% of Biodesix shares are owned by institutional investors. Comparatively, 36.9% of Enzo Biochem shares are owned by institutional investors. 69.2% of Biodesix shares are owned by insiders. Comparatively, 11.4% of Enzo Biochem shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has preferable earnings & valuation, BDSX or ENZ? Enzo Biochem has lower revenue, but higher earnings than Biodesix. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiodesix$65.56M3.48-$52.15M-$0.39-4.03Enzo Biochem$30.31M1.31-$26.08MN/AN/A Does the MarketBeat Community favor BDSX or ENZ? Enzo Biochem received 183 more outperform votes than Biodesix when rated by MarketBeat users. However, 74.36% of users gave Biodesix an outperform vote while only 54.78% of users gave Enzo Biochem an outperform vote. CompanyUnderperformOutperformBiodesixOutperform Votes2974.36% Underperform Votes1025.64% Enzo BiochemOutperform Votes21254.78% Underperform Votes17545.22% SummaryBiodesix beats Enzo Biochem on 10 of the 16 factors compared between the two stocks. Ad ProsperityPubThis Indicator called BOTH NVDA ralliesRarely would I label something as “the best” But in this rare instance, I believe this is THE BEST indicator for trading Nvida’s stock. Except, it’s not another tech stock like Nvidia. But rather a stock hiding in broad daylight… So, if you’d like to see what this stock is… Click this link here. Get Enzo Biochem News Delivered to You Automatically Sign up to receive the latest news and ratings for ENZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ENZ vs. The Competition Export to ExcelMetricEnzo BiochemMedical laboratories IndustryMedical SectorNYSE ExchangeMarket Cap$39.85M$2.93B$5.13B$19.18BDividend Yield57.14%15.63%5.08%3.61%P/E RatioN/A16.0289.5841.30Price / Sales1.31284.461,116.1217.58Price / CashN/A472.1142.8221.28Price / Book0.705.194.775.32Net Income-$26.08M-$32.86M$120.15M$989.88M7 Day Performance-25.23%-3.01%-1.92%-3.54%1 Month Performance-21.64%2.96%11.47%-3.68%1 Year Performance-45.52%12.37%30.54%12.14% Enzo Biochem Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ENZEnzo Biochem0.7795 of 5 stars$0.76+7.0%N/A-46.7%$39.85M$30.31M0.00520Earnings ReportAnalyst ForecastHigh Trading VolumeBDSXBiodesix2.5583 of 5 stars$1.33-0.7%$3.06+129.9%-4.8%$193.60M$65.56M-3.44220EUDAEUDA Health0.3174 of 5 stars$5.42-9.1%N/A+246.2%$133.48M$3.81M0.002QIPTQuipt Home Medical2.5539 of 5 stars$3.06+1.7%$6.25+104.2%-49.5%$131.86M$221.74M-27.361,200Earnings ReportAnalyst RevisionNews CoveragePositive NewsGap UpXGNExagen4.6627 of 5 stars$6.03+4.3%$7.00+16.1%+191.0%$106.37M$52.55M-6.14220High Trading VolumeBNRBurning Rock Biotech1.9789 of 5 stars$6.75+0.3%N/A-12.3%$69.15M$510.89M-2.241,390Positive NewsPIIIP3 Health Partners2.3841 of 5 stars$0.19-6.4%$2.38+1,138.3%-83.0%$68.82M$1.48B-0.24500News CoverageCCMConcord Medical Services0.3765 of 5 stars$4.99+0.8%N/A-58.8%$21.67M$471.70M0.00970Analyst ForecastNews CoverageGap DownTOIOncology Institute2.5303 of 5 stars$0.21-5.8%$2.50+1,090.5%-88.1%$15.87M$378.93M-0.29660Gap UpPMDPsychemedics1.3983 of 5 stars$2.67-1.8%N/A-5.3%$15.73M$22.10M0.00140Insider TradeGap DownHigh Trading VolumeMRAIMarpaiN/A$1.11-11.2%$6.00+440.5%-47.7%$15.25M$34.87M-0.42150Gap Down Related Companies and Tools Related Companies Biodesix Competitors EUDA Health Competitors Quipt Home Medical Competitors Exagen Competitors Burning Rock Biotech Competitors P3 Health Partners Competitors Concord Medical Services Competitors Oncology Institute Competitors Psychemedics Competitors Marpai Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:ENZ) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enzo Biochem, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enzo Biochem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ENZ Stock Alerts